Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism.

Neurobiology of aging - 1 May 2014

Trinh Joanne, Amouri Rim, Duda John E, Morley James F, Read Matthew, Donald Alan, Vilariño-Güell Carles, Thompson Christina, Szu Tu Chelsea, Gustavsson Emil K, Ben Sassi Samia, Hentati Emna, Zouari Mourad, Farhat Emna, Nabli Fatma, Hentati Faycel, Farrer Matthew J

Abstract excerpt

Parkinson disease is a progressive neurodegenerative disease for which leucine-rich repeat kinase 2 (LRRK2 carriers) p.G2019S confers substantial genotypic and population attributable risk. With informed consent, we have recruited clinical data from 778 patients from Tunisia (of which 266 have LRRK2 parkinsonism) and 580 unaffected subjects. Motor, autonomic, and cognitive assessments in idiopathic Parkinson...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Age of Onset

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Disease Progression

Share to Incidence

Share to Mutation

Share to Protein Serine-Threonine Kinases

Source

Identifiers

PMID: 24355527
DOI: 10.1016/j.neurobiolaging.2013.11.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism.PMID 24355527Read ↗

<i>LRRK2</i> parkinsonism in Tunisia and Norway: A comparative analysis of disease penetranceSemantic proximity Read ↗

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.Semantic proximity Read ↗

LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic.Semantic proximity Read ↗

Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.Semantic proximity Read ↗

The p.Gly2019Ser is the commonest pathogenic mutation in the LRRK2 gene among Egyptians with familial and sporadic Parkinson's diseaseSemantic proximity Read ↗

<i>LRRK2</i> p.G2385R and p.R1628P Variants in a Multi-Ethnic Asian Parkinson’s Cohort: Epidemiology and Clinical InsightsSemantic proximity Read ↗

LRRK2 in Parkinson's disease: genetic and clinical studies from patients.Semantic proximity Read ↗

The age at onset of LRRK2 p.Gly2019Ser Parkinson’s disease across ancestries and countries of originSemantic proximity Read ↗

Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.Semantic proximity Read ↗

Comprehensive analysis of clinical and biological features in Parkinson's disease associated with the LRRK2 G2019S mutation: Data from the PPMI study.Semantic proximity Read ↗

Analysis of LRRK2 G2019S carriers in the All of Us research program databaseSemantic proximity Read ↗

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.